These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29281577)

  • 1. Toward Better-Quality Compounded Drugs - An Update from the FDA.
    Woodcock J; Dohm J
    N Engl J Med; 2017 Dec; 377(26):2509-2512. PubMed ID: 29281577
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulating compounding pharmacies after NECC.
    Outterson K
    N Engl J Med; 2012 Nov; 367(21):1969-72. PubMed ID: 23134357
    [No Abstract]   [Full Text] [Related]  

  • 3. Compounding interest: a tragedy caused by contaminated steroids turned the spotlight on compounding pharmacies.
    Hinkley KN
    State Legis; 2013 Jun; 39(6):22-3. PubMed ID: 23805443
    [No Abstract]   [Full Text] [Related]  

  • 4. Fungal meningitis from injection of contaminated steroids: a compounding problem.
    Wilson LE; Blythe D; Sharfstein JM
    JAMA; 2012 Dec; 308(23):2461-2. PubMed ID: 23104261
    [No Abstract]   [Full Text] [Related]  

  • 5. How gaps in regulation of compounding pharmacy set the stage for a multistate fungal meningitis outbreak.
    Teshome BF; Reveles KR; Lee GC; Ryan L; Frei CR
    J Am Pharm Assoc (2003); 2014; 54(4):441-5. PubMed ID: 25063265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sterile products: advances and challenges in formulation, manufacturing and regulatory aspects--a regulatory review perspective.
    Hussong D
    AAPS PharmSciTech; 2010 Sep; 11(3):1482-4. PubMed ID: 20845091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDC probes new outbreak associated with compounded steroids.
    Kuehn BM
    JAMA; 2013 Jun; 309(24):2541. PubMed ID: 23800915
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug compounding, drug safety, and the first amendment.
    Dresser R
    Hastings Cent Rep; 2013; 43(2):9-10. PubMed ID: 23494695
    [No Abstract]   [Full Text] [Related]  

  • 9. Iatrogenic fungal meningitis: tragedy repeated.
    Perfect JR
    Ann Intern Med; 2012 Dec; 157(11):825-6. PubMed ID: 23080380
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmaceutical and Medical Devices: FDA Oversight.
    White RS;
    Issue Brief Health Policy Track Serv; 2015 Dec; ():1-97. PubMed ID: 27116797
    [No Abstract]   [Full Text] [Related]  

  • 11. Meningitis mess. The trouble with custom-made drugs.
    Park A
    Time; 2012 Oct; 180(18):18. PubMed ID: 23156104
    [No Abstract]   [Full Text] [Related]  

  • 12. Meningitis outbreak reveals gaps in US drug regulation.
    Alcorn T
    Lancet; 2012 Nov; 380(9853):1543-4. PubMed ID: 23130359
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA, states discuss pharmacy compounding regulatory framework.
    Traynor K
    Am J Health Syst Pharm; 2013 Feb; 70(3):180, 182. PubMed ID: 23327976
    [No Abstract]   [Full Text] [Related]  

  • 14. The Drug Quality and Security Act--mind the gaps.
    Outterson K
    N Engl J Med; 2014 Jan; 370(2):97-9. PubMed ID: 24369048
    [No Abstract]   [Full Text] [Related]  

  • 15. More US citizens die from meningitis as scope of inquiry widens.
    Davies E
    BMJ; 2012 Oct; 345():e7095. PubMed ID: 23086963
    [No Abstract]   [Full Text] [Related]  

  • 16. Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy.
    Pinkerton JV; Pickar JH
    Menopause; 2016 Feb; 23(2):215-23. PubMed ID: 26418479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sterility of extemporaneously compounded preservative-free injections.
    Levchuk JW
    Am J Hosp Pharm; 1991 Jan; 48(1):71-2. PubMed ID: 2053941
    [No Abstract]   [Full Text] [Related]  

  • 18. The Practice of Compounding, Associated Compounding Regulations, and the Impact on Dermatologists.
    Quertermous J; Desai S; Harper J; Lebwohl M; Torres A; Kircik LH
    J Drugs Dermatol; 2018 Jul; 17(7):s17-s22. PubMed ID: 30005109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sterile compounding: clinical, legal, and regulatory implications for patient safety.
    Qureshi N; Wesolowicz L; Stievater T; Lin AT
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1183-91. PubMed ID: 25443512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compounding pharmacy conundrum: "we cannot live without them but we cannot live with them" according to the present paradigm.
    Guharoy R; Noviasky J; Haydar Z; Fakih MG; Hartman C
    Chest; 2013 Apr; 143(4):896-900. PubMed ID: 23412546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.